The impact of arginine-modified chitosan-DNA nanoparticles on the function of macrophages

Journal of Nanoparticle Research

Volumn 12, Issue 5, 2010, Pages 1637-1644

  Liu, Lanxia ^a   Bai, Yuanyuan ^a   Song, Chunni ^a   Zhu, Dunwan ^a   Song, Liping ^a   Zhang, Hailing ^a   Dong, Xia ^a   Leng, Xigang ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Arginine; Chitosan; DNA nanoparticle; Macrophages cytokines; Nanobiotechnology

Indexed keywords

ARGININE; CYTOKINE PRODUCTION; CYTOKINES; EXPOSURE GROUPS; FOREIGN SUBSTANCES; INFLAMMATORY CYTOKINES; INFLAMMATORY RESPONSE; MODIFIED CHITOSAN; MURINE MACROPHAGES; NEGATIVE IMPACTS; PHAGOCYTIC ACTIVITY; TRANSGENICS;

AMINO ACIDS; CHITIN; CHITOSAN; DNA; GENES; NANOPARTICLES;

MACROPHAGES;

ARGININE; CHITOSAN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; INTERNALIZATION; MACROPHAGE FUNCTION; NANOBIOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 77955088599     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-009-9722-y     Document Type: Article

References (34)

1. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM (2004) Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 100:5-28
2. Anderson EJ, McGrath MA, Thalhamer T et al (2006) Interleukin- 12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting. Springer Semin Immunopathol 27:425-442
3. Binder H, Lindblom G (2004) A molecular view on the interaction of the trojan peptide penetratin with the polar interface of lipid bilayers. Biophys J 87:332-343
4. Bloomfield VA (1996) DNA condensation. Curr Opin Struct Biol 6:334-341
5. Cardarelli F, Serresi M, Bizzarri R et al (2007) In vivo study of HIV-1 Tat arginine-rich motif unveils its transport properties. Mol Ther 15:1313-1322
6. Chellat F, Grandjean-Laquerriere A, Le Naour R et al (2005) Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles. Biomaterials 26:961-970
7. Corsi K, Chellat F, Yahia L et al (2003) Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan- DNA nanoparticles. Biomaterials 24:1255-1264
8. Cui Z, Patel J, Tuzova M et al (2004) Strong T cell type-1 immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles. Vaccine 22:2631-2640
9. Erbacher P, Zou S, Bettinger T et al (1998) Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm Res 15: 1332-1339
10. Gupta B, Torchilin VP (2006) Transactivating transcriptional activator-mediated drug delivery. Expert Opin Drug Deliv 3:177-190
11. Johnston CJ, Finkelstein JN, Mercer P et al (2000) Pulmonary effects induced by ultrafine PTFE particles. Toxicol Appl Pharmacol 168:208-215
12. Kagan VE, Bayir H, Shvedova AA (2005) Nanomedicine and nanotoxicology: two sides of the same coin. Nanomedicine 1:313-316
13. Kanchan V, Panda AK (2007) Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response. Biomaterials 28:5344-5357
14. Kaplan IM, Wadia JS, Dowdy SF (2005) Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release 102:247-253
15. Liu WG, Yao KD (2002) Chitosan and its derivatives-a promising non-viral vector for gene transfection. J Control Release 83:1-11
16. Liu WG, Zhang JR, Cao ZQ et al (2004) A chitosan-arginine conjugate as a novel anticoagulation biomaterial. J Mater Sci: Mater Med 15:1199-1203
17. Liu LX, Song CN, Song LP et al (2009) Effects of alkylatedchitosan- DNA nanoparticles on the function of macrophages. J Mater Sci: Mater Med 20:943-948
18. MacLaughlin FC, Mumper RJ, Wang J et al (1998) Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release 56:259-272
19. Mansouri S, Lavigne P, Corsi K et al (2004) Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur J Pharm Biopharm 57:1-8
20. Mao HQ, Roy K, Troung-Le VL et al (2001) Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 70:399-421
21. Mege JL, Meghari S, Honstettre A et al (2006) The two faces of interleukin 10 in human infectious diseases. Lancet Infect Dis 6:557-569
22. Metselaar JM, Bruin P, de Boer LW et al (2003) A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity. Bioconjug Chem 14:1156-1164
23. Moghimi SM, Muir IS, Illum L et al (1993) Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim Biophys Acta 1179:157-165
24. Richardson SC, Kolbe HV, Duncan R (1999) Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int J Pharm 178:231-243
25. Rothen-Rutishauser B, Muhlfeld C, Blank F et al (2007) Translocation of particles and inflammatory responsesafter exposure to fine particles and nanoparticles in an epithelial airway model. Part Fibre Toxicol 4:9
26. Sayes CM, Reed KL, Warheit DB (2007) Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 97:163-180
27. Takeuchi H, Kojima H, Yamamoto H et al (2001) Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats. J Control Release 75:83-91
28. Taylor A, Verhagen J, Blaser K et al (2006) Mechanisms of immune suppression by interleukin-10 and transforminggrowth factor-beta: the role of T regulatory cells. Immunology 117:433-442
29. Whiteman KR, Subr V, Ulbrich K et al (2001) Poly(Hpma)- coated liposomes demonstrate prolonged circulation in mice. J Liposome Res 11:153-164
30. Woodle MC, Lasic DD (1992) Sterically stabilized liposomes. Biochim Biophys Acta 1113:171-199
31. Zahr AS, Davis CA, Pishko MV (2006) Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). Langmuir 22:8178-8185
32. Zhang HL, Zhu DW, Yang J et al (2006) Cellular uptake and cytotoxicity of modified chitosans as gene carriers. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 28:486-491
33. Zheng C, Brownlie R, Babiuk LA et al (2005) Characterization of the nuclear localization and nuclear export signals of bovine herpesvirus 1 VP22. J Virol 79:11864-11872
34. Zhu DW, Zhang HL, Bo JG et al (2007) Enhancement of transfection efficiency for HeLa cells via incorporating arginine moiety into chitosan. Chin Sci Bull 52:3207-3215